Li-Jiuan Shen, Ph.D. - Publications

Affiliations: 
2004 University of Southern California, Los Angeles, CA, United States 
Area:
Pharmacology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Lin CH, Hsiao FY, Liu YB, Gau SS, Wang CC, Shen LJ. Antidepressants and Valvular Heart Disease: A Nested Case-Control Study in Taiwan. Medicine. 95: e3172. PMID 27057841 DOI: 10.1097/MD.0000000000003172  0.32
2015 Yeh TH, Chen YR, Chen SY, Shen WC, Ann DK, Zaro JL, Shen LJ. Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Molecular Pharmaceutics. PMID 26642391 DOI: 10.1021/acs.molpharmaceut.5b00706  0.32
2015 Chen HL, Shen LJ, Wei CP, Lu HM, Hsiao FY. Decision to adopt medical technology under the National Health Insurance System in Taiwan: case study of new molecular targeted drugs among non-small cell lung cancer patients. Journal of Evaluation in Clinical Practice. PMID 26096761 DOI: 10.1111/jep.12382  0.32
2015 Chew TW, Gau CS, Wen YW, Shen LJ, Mullins CD, Hsiao FY. Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study. Bmc Cancer. 15: 298. PMID 25925555 DOI: 10.1186/s12885-015-1200-6  0.32
2014 Lin SC, Huang CF, Shen LJ, Wang HJ, Lin CY, Wu FL. Formulation and stability of an extemporaneous 0.02% chlorhexidine digluconate ophthalmic solution. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 25260549 DOI: 10.1016/j.jfma.2014.08.003  0.32
2014 Jagtap AD, Chang PT, Liu JR, Wang HC, Kondekar NB, Shen LJ, Tseng HW, Chen GS, Chern JW. Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia. European Journal of Medicinal Chemistry. 85: 268-88. PMID 25089810 DOI: 10.1016/j.ejmech.2014.07.108  0.32
2014 Wu FL, Yeh TH, Chen YL, Chiu YC, Cheng JC, Wei MF, Shen LJ. Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Molecular Pharmaceutics. 11: 2777-86. PMID 24950134 DOI: 10.1021/mp5001372  0.32
2014 Liao YT, Kuo SC, Lee YT, Chen CP, Lin SW, Shen LJ, Fung CP, Cho WL, Chen TL. Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection. Antimicrobial Agents and Chemotherapy. 58: 3983-90. PMID 24798276 DOI: 10.1128/AAC.02636-13  0.32
2014 Yeh TH, Wu FL, Shen LJ. Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells. Journal of Drug Targeting. 22: 528-35. PMID 24731058 DOI: 10.3109/1061186X.2014.905947  0.32
2014 Qiu F, Chen YR, Liu X, Chu CY, Shen LJ, Xu J, Gaur S, Forman HJ, Zhang H, Zheng S, Yen Y, Huang J, Kung HJ, Ann DK. Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells. Science Signaling. 7: ra31. PMID 24692592 DOI: 10.1126/scisignal.2004761  0.36
2014 Lin CF, Shen LJ, Hsiao FY, Gau CS, Wu FL. Sex differences in the treatment and outcome of patients with acute coronary syndrome after percutaneous coronary intervention: a population-based study. Journal of Women's Health (2002). 23: 238-45. PMID 24286239 DOI: 10.1089/jwh.2013.4474  0.32
2013 Liao HW, Tsai IL, Chen GY, Kuo CT, Wei MF, Hwang TJ, Chen WJ, Shen LJ, Kuo CH. Simultaneous detection of single nucleotide polymorphisms and copy number variations in the CYP2D6 gene by multiplex polymerase chain reaction combined with capillary electrophoresis. Analytica Chimica Acta. 763: 67-75. PMID 23340288 DOI: 10.1016/j.aca.2012.12.005  0.32
2012 Wu FL, Chen YM, Lai TS, Shen LJ, Ho YF, Lee YT, Wu MS, Lin SL, Wu KD. Does Chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan? Nephron. Clinical Practice. 120: c215-22. PMID 23051619 DOI: 10.1159/000341120  0.32
2006 Shen LJ, Shen WC. Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers. Current Opinion in Molecular Therapeutics. 8: 240-8. PMID 16774044  1
2006 Shen LJ, Beloussow K, Shen WC. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase. Cancer Letters. 231: 30-5. PMID 16356828 DOI: 10.1016/j.canlet.2005.01.007  1
2005 Shen LJ, Beloussow K, Shen WC. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochemical Pharmacology. 69: 97-104. PMID 15588718 DOI: 10.1016/j.bcp.2004.09.003  1
2003 Shen LJ, Lin WC, Beloussow K, Hosoya K, Terasaki T, Ann DK, Shen WC. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochemical Pharmacology. 66: 1945-52. PMID 14599552  1
2003 Shen LJ, Lin WC, Beloussow K, Shen WC. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Letters. 191: 165-70. PMID 12618329  1
Show low-probability matches.